Benjamin Li

Chief Executive Officer at China Oncology Focus Ltd.

Health Technology

Profile

Benjamin Li currently works at China Oncology Focus Ltd., as Chief Executive Officer and Zhaoke (Hong Kong) Ophthalmology Pharmaceutical Ltd., as Chairman.

Benjamin Li active positions

Companies	Position	Start
China Oncology Focus Ltd. China Oncology Focus Ltd. Pharmaceuticals: MajorHealth Technology China Oncology Focus Ltd. operates as a drug development company. The firm specializes in oncology disease area. The company is headquartered in Road Town, British Virgin Islands.	Chief Executive Officer	-
Zhaoke (Hong Kong) Ophthalmology Pharmaceutical Ltd. Zhaoke (Hong Kong) Ophthalmology Pharmaceutical Ltd. Pharmaceuticals: MajorHealth Technology Zhaoke (Hong Kong) Ophthalmology Pharmaceutical Ltd. engages in the development of eye treatment. It also focuses on licensing potential ophthalmology products and introduce it as accessible and affordable therapies to patients suffering from ophthalmic diseases in China. The company was founded on July 24, 2017 and is headquartered in Hong Kong.	Chairman	-

All active positions of Benjamin Li

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Benjamin Li's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
China Oncology Focus Ltd. China Oncology Focus Ltd. Pharmaceuticals: MajorHealth Technology China Oncology Focus Ltd. operates as a drug development company. The firm specializes in oncology disease area. The company is headquartered in Road Town, British Virgin Islands.	Health Technology
Zhaoke (Hong Kong) Ophthalmology Pharmaceutical Ltd. Zhaoke (Hong Kong) Ophthalmology Pharmaceutical Ltd. Pharmaceuticals: MajorHealth Technology Zhaoke (Hong Kong) Ophthalmology Pharmaceutical Ltd. engages in the development of eye treatment. It also focuses on licensing potential ophthalmology products and introduce it as accessible and affordable therapies to patients suffering from ophthalmic diseases in China. The company was founded on July 24, 2017 and is headquartered in Hong Kong.	Health Technology